Alterity Therapeutics Limited ATHE
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -15.98M | -12.68M | -9.45M | -8.64M | -7.89M |
| Total Depreciation and Amortization | 78.40K | 79.40K | 80.50K | 85.20K | 90.60K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.02M | 2.38M | 1.75M | 1.25M | 762.30K |
| Change in Net Operating Assets | -2.44M | -1.86M | -1.29M | -857.50K | -443.00K |
| Cash from Operations | -15.32M | -12.08M | -8.92M | -8.16M | -7.48M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 4.91M | 2.51M | 160.20K | -2.30M | -4.75M |
| Cash from Investing | 4.91M | 2.51M | 160.20K | -2.30M | -4.75M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -136.60K | -130.80K | -125.00K | -126.00K | -127.00K |
| Issuance of Common Stock | 20.38M | 41.46M | 62.55M | 52.56M | 42.57M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.11M | -2.48M | -3.85M | -3.31M | -2.77M |
| Cash from Financing | 12.53M | 25.17M | 37.54M | 31.34M | 25.16M |
| Foreign Exchange rate Adjustments | 38.00K | -44.40K | -125.10K | -125.80K | -126.90K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2.17M | 15.56M | 28.66M | 20.75M | 12.79M |